avx101
Vaccineexperimental
Clinical trial activity
2 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2003 (NCT00063778)
Timeline
2000s
- Jan 1, 2003
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- avx101
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00097838 | Phase 1 | Oct 1, 2004 | AlphaVax, Inc., HIV Vaccine Trials Network, Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID), University of Kwa-Zulu Natal |
| NCT00063778 | Phase 1 | Jul 1, 2003 | AlphaVax, Inc., HIV Vaccine Trials Network, Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID), University of Natal |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AlphaVax, Inc. | For profit | 2 | 2 | 1 | 2003 |
| HIV Vaccine Trials Network | Academic/Hospital | 2 | 0 | 1 | 2003 |
| Johns Hopkins University | Academic/Hospital | 2 | 0 | 1 | 2003 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 2 | 0 | 1 | 2003 |
| University of Kwa-Zulu Natal | Academic/Hospital | 1 | 0 | 1 | 2004 |
| University of Natal | Academic/Hospital | 1 | 0 | 1 | 2003 |
6 organizations
Page 1 / 1